196
Participants
Start Date
October 29, 2024
Primary Completion Date
December 12, 2031
Study Completion Date
December 12, 2031
Guselkumab
Guselkumab will be administered as subcutaneous injection.
RECRUITING
Hosp. Clinico Univ. de Santiago, Santiago de Compostela
RECRUITING
Schon Klinik Hamburg Eilbek, Hamburg
RECRUITING
Umraniye Training and Research Hospital, Istanbul
RECRUITING
University of Utah, Salt Lake City
RECRUITING
Capital Center For Children's health Capital Medical University, Beijing
RECRUITING
Shengjing Hospital Of China Medical University, Shenyang
RECRUITING
Ruijin Hospital Shanghai Jiao Tong University, Shanghai
RECRUITING
Changzhou No 2 Peoples Hospital, Changzhou
RECRUITING
The Childrens Hospital Zhejiang University School Of Medicine, Hangzhou
RECRUITING
Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou
RECRUITING
Instituto Caici, Rosario
RECRUITING
Kanazawa University Hospital, Kanazawa
RECRUITING
Kobe University Hospital, Kobe
RECRUITING
Japanese Red Cross Kumamoto Hospital, Kumamoto
RECRUITING
Saga University Hospital, Saga
RECRUITING
Medical Network, Warsaw
RECRUITING
Instytut Pomnik Centrum Zdrowia Dziecka, Warsaw
RECRUITING
Gazi University Medical Faculty, Ankara
Janssen Research & Development, LLC
INDUSTRY